A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2016
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Pneumonia; Skin infections; Soft tissue infections; Urinary tract infections
- Focus Pharmacokinetics
- 31 Oct 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
- 31 Oct 2016 Planned initiation date changed from 1 Jul 2016 to 1 Jan 2017.
- 14 Jul 2016 New trial record